Compare Lime Chemicals with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -20.32% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) of 2.56 times
Flat results in Mar 26
Risky - Negative EBITDA
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Commodity Chemicals
INR 10 Cr (Micro Cap)
NA (Loss Making)
43
0.00%
2.47
-10.06%
5.45
Total Returns (Price + Dividend) 
Latest dividend: 0.9700 per share ex-dividend date: Sep-25-2006
Risk Adjusted Returns v/s 
Returns Beta
News

Lime Chemicals Ltd Upgraded to Sell on Technical Improvement Despite Weak Fundamentals
Lime Chemicals Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 7 August 2026, primarily driven by a shift in technical indicators signalling a mildly bullish trend. Despite this upgrade, the company continues to face significant challenges in its financial performance and valuation metrics, reflecting ongoing operational and structural weaknesses in the commodity chemicals sector.
Read full news articleWhen is the next results date for Lime Chemicals Ltd?
The next results date for Lime Chemicals Ltd is scheduled for 14 August 2026....
Read full news article
Lime Chemicals Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals
Lime Chemicals Ltd, a micro-cap player in the commodity chemicals sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 27 Jul 2026. This revision reflects deteriorating technical indicators, weak financial trends, poor valuation metrics, and declining quality scores, signalling heightened risk for investors amid ongoing operational challenges and market underperformance.
Read full news article Announcements 
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Approval Of Shifting Of Registered Office By The Regional Director.
07-Aug-2026 | Source : BSEApproval from Regional Director of Western Region-II Shifting of Registered Office of the Company from Jursidiction of ROC Mumbai-II to Jurisdiction of ROC-Mumbai I
Announcement under Regulation 30 (LODR)-Change in Directorate
04-Aug-2026 | Source : BSEThe details of resignation and appointment of Directors is attached.
Board Meeting Intimation for Board Meeting On 14Th August 2026 To Approve Unaudited Financial Results For The Quarter Ended On 30Th June 2026
04-Aug-2026 | Source : BSELime Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve A meeting of the Board of Directors of the Company will be held on Friday the 14th August 2026 to approve unaudited financial results for the quarter ended on 30th June 2026.
Corporate Actions 
14 Aug 2026
Lime Chemicals Ltd has declared 12% dividend, ex-date: 25 Sep 06
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 5 Schemes (0.05%)
Held by 0 FIIs
Rahim Ahmed Dawoodani (10.62%)
Devanshi Parimal Merchant (12.3%)
64.67%
Quarterly Results Snapshot (Standalone) - Mar'26 - YoY
YoY Growth in quarter ended Mar 2026 is 39.02% vs -30.51% in Mar 2025
YoY Growth in quarter ended Mar 2026 is -50.00% vs 154.55% in Mar 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -38.93% vs -1.45% in Sep 2024
Growth in half year ended Sep 2025 is -230.00% vs 131.25% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -39.65% vs -0.87% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -231.25% vs 142.11% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is -26.37% vs -7.46% in Mar 2025
YoY Growth in year ended Mar 2026 is -177.27% vs 144.90% in Mar 2025






